It has been reported that ERα binding to DSCAM-AS1 promoter is high in tumor tissues from patients unresponsive to Tamoxifen treatment and that DSCAM-AS1 expression is upregulated in Tamoxifen-resistant cellular models [22], contrary to typical estrogen-responsive genes that are strongly downregulated. Here, ESR1 is linked to neoplasm.